|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 1 (July 1), 1999:
pp. 368-371
A Clinical Trial of Retroviral-Mediated Transfer of a
rev-Responsive Element Decoy Gene Into CD34+
Cells From the Bone Marrow of Human Immunodeficiency Virus-1-Infected
Children
Donald B. Kohn,
Gerhard Bauer,
C. Robert Rice,
J.C. Rothschild,
Denise A. Carbonaro,
Penelope Valdez,
Qian-lin Hao,
Chen Zhou,
Ingrid Bahner,
Karen Kearns,
Kate Brody,
Sarah Fox,
Elizabeth Haden,
Kathy Wilson,
Cathy Salata,
Cathy Dolan,
Charles Wetter,
Estuardo Aguilar-Cordova, and
Joseph Church
From the Division of Research Immunology/Bone Marrow Transplantation
and the Division of Immunology/Allergy, Childrens Hospital Los Angeles,
the Department of Pediatrics, University of Southern California School
of Medicine; and Gene Vector Laboratories, Texas Children's Cancer
Center, Baylor College of Medicine, Houston, TX.
Genetic modification of hematopoietic stem cells with genes that
inhibit replication of human immunodeficiency virus-1 (HIV-1) could
lead to development of T lymphocytes and monocytic cells resistant to
HIV-1 infection after transplantation. We performed a clinical trial to
evaluate the safety and feasibility of this procedure, using bone
marrow from four HIV-1-infected pediatric subjects (ages 8 to 17 years). We obtained bone marrow, isolated CD34+ cells,
performed in vitro transduction with a retroviral vector carrying a
rev-responsive element (RRE) decoy gene, and reinfused the
cells into these subjects with no evidence of adverse effects. The
levels of gene-containing leukocytes in peripheral blood samples in the
1 year after gene transfer/cell infusion have been extremely low. These
observations support the potential of performing gene therapy for HIV-1
using hematopoietic cells, but emphasize the need for improved gene
transfer techniques.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. L. Lucas, N. E. Seidel, C. D. Porada, J. G. Quigley, S. M. Anderson, H. L. Malech, J. L. Abkowitz, E. D. Zanjani, and D. M. Bodine
Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes
Blood,
July 1, 2005;
106(1):
51 - 58.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Egelhofer, G. Brandenburg, H. Martinius, P. Schult-Dietrich, G. Melikyan, R. Kunert, C. Baum, I. Choi, A. Alexandrov, and D. von Laer
Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides
J. Virol.,
January 15, 2004;
78(2):
568 - 575.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.-K. Zaiss, S. Son, and L.-J. Chang
RNA 3' Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and Efficacy
J. Virol.,
June 14, 2002;
76(14):
7209 - 7219.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. S. Fisher, P. Joshi, and V. R. Prasad
Mutations That Confer Resistance to Template-Analog Inhibitors of Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Lead to Severe Defects in HIV Replication
J. Virol.,
March 19, 2002;
76(8):
4068 - 4072.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Cutler, S. Giri, S. Jeyapalan, D. Paniagua, A. Viswanathan, and J. H. Antin
Acute and Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell and Bone Marrow Transplantation: A Meta-Analysis
J. Clin. Oncol.,
August 15, 2001;
19(16):
3685 - 3691.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Rosenzweig, M. Connole, R. Glickman, S.-P. S. Yue, B. Noren, M. DeMaria, and R. P. Johnson
Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34+ hematopoietic cells
Blood,
April 1, 2001;
97(7):
1951 - 1959.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. N. Deininger, J. M. Goldman, and J. V. Melo
The molecular biology of chronic myeloid leukemia
Blood,
November 15, 2000;
96(10):
3343 - 3356.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Klug, S. Cheshier, and I. L. Weissman
Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny
Blood,
August 1, 2000;
96(3):
894 - 901.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Romano, P. Micheli, C. Pacilio, and A. Giordano
Latest Developments in Gene Transfer Technology: Achievements, Perspectives, and Controversies over Therapeutic Applications
Stem Cells,
January 1, 2000;
18(1):
19 - 39.
[Abstract]
[Full Text]
|
|
|
|
|
